Document is current
Any future updates will be listed below
-
Authors
Shi, Honglei
Wang, Ying
Wang, Min
Shen, Dan
Huang, Kewu
-
Funding
Funding for this research was provided by:
Sanofi and Regeneron Pharmaceuticals Inc.
- License Information
-
More Information
Article History
Received: 1 June 2026
Accepted: 30 June 2026
First Online: 21 July 2026
Declarations
Conflict of interest: Kewu Huang, Honglei Shi, and Ying Wang: nothing to disclose. Min Wang, Dan Shen, Sanofi employees, may hold stock and/or stock options in the company. Min Wang is currently affiliated with AstraZeneca.
Ethical Approval: The study protocol and its amendments were approved by medical ethics committee of Beijing Chao-Yang Hospital (2023-KE-332). This study was conducted in accordance with the Ethical Guidelines for Biomedical Research Involving Human Subjects, the ethical principles of the Declaration of Helsinki, and all relevant regulations applicable to noninterventional studies. The need for informed consent was waived as data available in the database are standardized and anonymized.
